688488.SH
艾迪药业
SSE · Healthcare · Biotechnology · CN
CNY 15.93
−3.40%Margins
Gross margin
68.3%
EBITDA margin
15.2%
EBIT margin
4.9%
Net margin
-3.9%
FCF margin
-9.5%
-2.8%
Return on equity
-1.3%
Return on assets
2.1%
Return on invested capital
0.35x
Asset turnover
-CNY 21.2M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026